PURL: An alternative regimen to reduce risk of asthma exacerbations
- PMID: 33760899
- DOI: 10.12788/jfp.0154
PURL: An alternative regimen to reduce risk of asthma exacerbations
Abstract
This study supports the use of an ICS/LABA as needed for adults with intermittent, mild persistent, and moderate persistent asthma.
Comment on
-
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.Lancet. 2019 Sep 14;394(10202):919-928. doi: 10.1016/S0140-6736(19)31948-8. Epub 2019 Aug 23. Lancet. 2019. PMID: 31451207 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical